In addition, recent work has further implicated BRAF alteration as a poor prognostic marker in patients with unresectable metastatic colorectal cancer.7 In contrast to these studies, our current study focused on OS in the main study cohort and did not examine patterns of failure after hepatectomy. Here, BRAF is linked to metastatic colorectal cancer.